C18 Ganglioside GD3-d7 (d18:1/18:0-d7) (ammonium salt, synthetic) and 6 more items

The University of Virginia awarded a purchase order (A207_PO-0467660) to Quartzy on August 11, 2026, for the procurement of specialized biochemical research materials and assay kits. The cumulative contract value totals $3,098.34. All materials are designated for delivery to Luke Remington Vass and include seven distinct line items: C18 Ganglioside GD3-d7 (d18:1/18:0-d7) ammonium salt (synthetic) at $538.02; C16 Ganglioside GM1-d9 (d18:1/16:0-d9) ammonium salt at $873.26; Lactate Dehydrogenase (LDH) Cytotoxicity Assay Kit at $515.12; Purified Mixed Gangliosides (porcine) ammonium salt at $174.84 per milligram; Thapsigargin at $60.72 per milligram; C6 Glucosylceramide (d18:1/6:0) at $469.20 per milligram; and C16 Ganglioside GM3-d9 (d18:1/16:0-d9) ammonium salt (synthetic) at $467.18.

These materials represent research-grade biochemical compounds and diagnostic assay kits utilized in laboratory and cellular research applications. The procurement reflects the University of Virginia's acquisition of specialized ganglioside derivatives, glucosylceramide, thapsigargin, and associated cytotoxicity testing materials, suggesting applications in pharmaceutical development, cellular biology research, or related scientific investigations. No specific period of performance is documented in the contract award information provided.